Results 1-3 of 3 for hpv segment:8281169

Joint Oireachtas Committee on Health: HSE National Service Plan 2022: Discussion (18 May 2022)

Martin Conway: That is great. The witnesses might provide a progress note to the committee, perhaps in three or four weeks, as to how the impact is being addressed. Another issue is the HPV vaccine, specifically the catch-up programme. I understand that the Minister asked the National Immunisation Advisory Committee, NIAC, for a recommendation and that that recommendation has now been sent from NIAC to...

Joint Oireachtas Committee on Health: HSE National Service Plan 2022: Discussion (18 May 2022)

Dr. Colm Henry: With the HPV vaccine we had seen great progress from initial low uptake. The pandemic affected many of our established vaccination programmes. I am happy to come back to the committee with a report on the current uptake and our plans to improve uptake further. Improvement was due largely to the work of advocates such as the late Ms Laura Brennan and others who worked...

Joint Oireachtas Committee on Health: HSE National Service Plan 2022: Discussion (18 May 2022)

...programme is quite good at about 78% of the eligible population. The screening age range is from 25 to 65 with increased frequency in the first few years, reflecting the higher prevalence of HPV infection in younger age groups. It broadens out to five-year intervals thereafter. In March 2020, just before the pandemic, we switched over to the HPV form of screening, which is more...